🔎 Trials Near Me

Beranda › Gangguan Saraf Perifer › New York

Uji klinis Gangguan Saraf Perifer di New York

7 studi untuk Gangguan Saraf Perifer mencari peserta di lokasi di New York.

Kota di New York

Teks studi resmi (Bahasa Inggris)

Natural History Study for Charcot Marie Tooth Disease

  • Hereditary Neuropathy Foundation, New York
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT05902351

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

  • Ichan School of Medicine at Mount Sinai, New York
  • University of Rochester, Rochester
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06614322

Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer

  • Montefiore Medical Center, The Bronx
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07109817

This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.

  • NYU Langone Health, New York
Menerima pesertaFase 3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06616025

Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems

  • Dent Neurologic Institute, Amherst
Menerima peserta
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT06959277

A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair

  • NYU Langone Orthopedic Center, New York
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT06529835

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

  • Start New York, LLC, Lake Success
  • MSK, New York
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Jun 2026 · NCT07484022

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.